Once-daily oxymetazoline 0.1% in patients with acquired blepharoptosis - Video abstract [ID 322326]

Video abstract of an original research "Safety of once-daily oxymetazoline HCl ophthalmic solution, 0.1% in patients with acquired blepharoptosis: results from four randomized, double-masked clinical trials" published in the open access journal Clinical Ophthalmology by David Wirta, Michael Korenfeld, Shane Foster et al. Read the full paper here: https://www.dovepress.com/safety-of-once-daily-oxymetazoline-hcl-ophthalmic-solution-01-in-patie-peer-reviewed-fulltext-article-OPTH